Trending...
- Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
- Heritage at Manalapan Welcomes New Sales Team as Luxury Single-Family Home Community Continues to Grow
- Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
FAYETTEVILLE, Ark. - nvtip -- Lineus Medical continues to expand the patent protection of its flagship product, SafeBreak Vascular, a break-away medical device technology that helps protect IV lines. The company was awarded United States utility patent US10655768B2 that covers several key features of the device. This is the third patent awarded to Lineus Medical, which now has two utility patents and one design patent pertaining to SafeBreak Vascular.
SafeBreak Vascular is a first of its kind breakaway medical device designed for peripheral IV lines. When a damaging level of force is applied to an IV line, SafeBreak Vascular purposefully separates to minimize the effects of the damaging force and to prevent patient bleeding and the spillage of medication. Vance Clement, CEO of Lineus Medical said, "This issuance of this new utility patent is another important step in adding value to our company and protecting our first product to market, SafeBreak Vascular. The portfolio of patents the company has secured puts the company in a strong intellectual property position to protect and defend its value and SafeBreak Vascular from competition."
More on nvtip.com
Spencer Jones, Chief Technology Officer and Founder of Lineus Medical commented, "We continue to build an intellectual property moat around SafeBreak Vascular, and that moat just became more difficult to overcome. Innovation in product design must be accompanied by meaningful patent protection, and we expect that our issued patents and patents currently under review will further protect our technologies and set-us apart for many years in the market place."
ABOUT LINEUS MEDICAL
Lineus Medical is a developer of medical device technologies that serve the vascular access/IV market. The company develops products that help prevent pain and discomfort in patients, save nurses time and control costs for hospitals. SafeBreak Vascular is not yet FDA cleared and is not yet for sale. More information about Lineus Medical is available at www.lineusmed.com.
MKG-0068 Rev 00
SafeBreak Vascular is a first of its kind breakaway medical device designed for peripheral IV lines. When a damaging level of force is applied to an IV line, SafeBreak Vascular purposefully separates to minimize the effects of the damaging force and to prevent patient bleeding and the spillage of medication. Vance Clement, CEO of Lineus Medical said, "This issuance of this new utility patent is another important step in adding value to our company and protecting our first product to market, SafeBreak Vascular. The portfolio of patents the company has secured puts the company in a strong intellectual property position to protect and defend its value and SafeBreak Vascular from competition."
More on nvtip.com
- Lawsuit Alleges American Deli Food Caused Severe Illness, Acute Kidney Failure, And Eight-day Hospitalization
- FBI/DoW plot uncovered to hurt Trump/Vance through encouraged "widespread" cybersecurity breaches and racketeering theft of $80m in USDA payments
- Bettingbladet releases H1 2026 report on the Swedish online gambling market
- Garage door installation or repair in Minnesota? Which makes more sense for your family?
- Super Rooter Expands to 190 Plumbing, Sewer, and Drain Service Locations Across the United States
Spencer Jones, Chief Technology Officer and Founder of Lineus Medical commented, "We continue to build an intellectual property moat around SafeBreak Vascular, and that moat just became more difficult to overcome. Innovation in product design must be accompanied by meaningful patent protection, and we expect that our issued patents and patents currently under review will further protect our technologies and set-us apart for many years in the market place."
ABOUT LINEUS MEDICAL
Lineus Medical is a developer of medical device technologies that serve the vascular access/IV market. The company develops products that help prevent pain and discomfort in patients, save nurses time and control costs for hospitals. SafeBreak Vascular is not yet FDA cleared and is not yet for sale. More information about Lineus Medical is available at www.lineusmed.com.
MKG-0068 Rev 00
Source: Lineus Medical
Filed Under: Health
0 Comments
Latest on nvtip.com
- Kerri Lawless Introduces New Home-Selling Option for Local Homeowners
- Government partnership brings Flash Biometrics to Las Vegas' largest venues
- Flash Biometrics Partners with Nevada Athletic Commission on Identity Verification
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
- Shelter Structures America makes European debut at TEMPOR EXPO 2026 in Fulda, Germany
- HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
- Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
- OneVizion Launches Vera AI, Bringing Connected Operational Context to Infrastructure Teams
- P-Wave Press Announces Pushing the Wave 2025 by L.A. Davenport
- DONGSHENG Titanium Recycling: Promoting a Closed-Loop Cycle for High-End Titanium Materials
- French Camp Academy Releases New Video Inviting Individuals to Consider a Life of Service
- LET US READ Documentary on Dyslexia and Literacy to Screen at TCL Chinese 6 in Hollywood
- Back-to-College Organization Starts at Home with PODS® Las Vegas
- Don Barnhart Brings His NFTG Tour Home as Delirious Celebrates One Year at Silver Sevens
- Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
- STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
- Soft Water Nevada Announces Labor Day $995 Water Softener & Reverse Osmosis Special for Las Vegas Homeowners
- Boulder City Hospital Awarded $2.65+ Million Rural Health Transformation Initiative Grant



